CompletedNot Applicable

A Waiting Room-Delivered Video to Enhance Clinical Outcomes Among Persons Living With HIV

4,003 participantsStarted 2016-06-01

Plain-language summary

The purpose of this project is to beta-test a brief waiting room video intervention that promotes early initiation of antiretroviral treatment among treatment-naïve HIV-positive patients, adherence to antiretroviral treatment and retention in care among HIV-positive patients currently on therapy, sexual risk reduction tailored to HIV-positive persons, and patient-initiated discussion of these topics with their health providers. The video is currently being created, and will be ready for beta-testing by June 1, 2016. Results of the beta-testing will be used to refine and improve the video before dissemination to HIV/AIDS treatment facilities nationally. This video project is being funded by the Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention (DHAP).

Who can participate

Age range18 Years – 87 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. located in a jurisdiction with high AIDS prevalence;
✓. managing more than 500 unique HIV-positive patients annually;
✓. serving minority persons such that minimally 55% of the clinic population is African-American and Hispanic/Latino;
✓. at least 163 patients have unsuppressed viral load;
✓. utilizing an electronic medical record (EMR) system; and
✓. not participating in another behavioral intervention research project during the historical comparison data period (August 2015 through May 2016) or during the 10-month intervention period (June 2016 through March 2017).

What they're measuring

Antiretroviral therapy (ART) medication adherence (suppression level)

Timeframe: By 6 months (183 days) after the patient's index (first) visit to the clinic

Antiretroviral therapy (ART) medication adherence (undetectable level)

Timeframe: By 6 months (183 days) after the patient's index (first) visit to the clinic

Trial details

NCT IDNCT03508310

SponsorCenters for Disease Control and Prevention

Sponsor typeFED

Study typeINTERVENTIONAL

Primary completion2017-03-30

View on ClinicalTrials.gov More HIV Infections trials

Plain-language summary

Who can participate

Age range18 Years – 87 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. located in a jurisdiction with high AIDS prevalence;
✓. managing more than 500 unique HIV-positive patients annually;
✓. serving minority persons such that minimally 55% of the clinic population is African-American and Hispanic/Latino;
✓. at least 163 patients have unsuppressed viral load;
✓. utilizing an electronic medical record (EMR) system; and
✓. not participating in another behavioral intervention research project during the historical comparison data period (August 2015 through May 2016) or during the 10-month intervention period (June 2016 through March 2017).

What they're measuring

Antiretroviral therapy (ART) medication adherence (suppression level)

Timeframe: By 6 months (183 days) after the patient's index (first) visit to the clinic

Antiretroviral therapy (ART) medication adherence (undetectable level)

Timeframe: By 6 months (183 days) after the patient's index (first) visit to the clinic